Detalhe da pesquisa
1.
Clinical characteristics and outcomes of extranodal stage I diffuse large B-cell lymphoma in the rituximab era.
Blood
; 137(1): 39-48, 2021 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32730585
2.
Novel therapeutic agents for relapsed classical Hodgkin lymphoma.
Br J Haematol
; 184(1): 105-112, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30536386
3.
Cost-effectiveness analysis of consolidation with brentuximab vedotin for high-risk Hodgkin lymphoma after autologous stem cell transplantation.
Cancer
; 123(19): 3763-3771, 2017 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28640385
4.
Vemurafenib and Obinutuzumab as Frontline Therapy for Hairy Cell Leukemia.
NEJM Evid
; 2(10): EVIDoa2300074, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-38320179
5.
Nivolumab for relapsed/refractory classical Hodgkin lymphoma: 5-year survival from the pivotal phase 2 CheckMate 205 study.
Blood Adv
; 7(20): 6266-6274, 2023 10 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37530622
6.
Outcomes of Patients with Positive Interim Positron Emission Tomography (PET) Continuing ABVD in the Clinical Setting.
Cancers (Basel)
; 15(6)2023 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36980646
7.
The metabolic stress-activated checkpoint LKB1-MARK3 axis acts as a tumor suppressor in high-grade serous ovarian carcinoma.
Commun Biol
; 5(1): 39, 2022 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35017636
8.
Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphoma.
Leuk Lymphoma
; 63(4): 821-833, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34865586
9.
Successful implementation of outpatient R ± DHAX (rituximab, dexamethasone, oxaliplatin, cytarabine) for select patients with lymphoma: a single-center experience.
Leuk Lymphoma
; 63(4): 876-884, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34784853
10.
Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma.
Blood Cancer J
; 12(2): 29, 2022 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35145059
11.
The role of tazemetostat in relapsed/refractory follicular lymphoma.
Ther Adv Hematol
; 12: 20406207211015882, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34104370
12.
How we treat mature B-cell neoplasms (indolent B-cell lymphomas).
J Hematol Oncol
; 14(1): 5, 2021 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33407745
13.
Substance-Related Found-Down Compartment Syndrome: A Systematic Review.
J Orthop Trauma
; 35(7): e247-e253, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33177431
14.
Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse.
Blood Cancer J
; 11(6): 113, 2021 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34135307
15.
Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma.
J Clin Oncol
; 39(28): 3109-3117, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34170745
16.
Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphoma.
Blood Adv
; 4(14): 3382-3390, 2020 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32722781
17.
Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies.
Blood Adv
; 4(19): 4669-4678, 2020 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33002134
18.
Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups.
Blood Cancer J
; 10(7): 74, 2020 07 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32678074
19.
Positron-emission tomography-based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma.
Eur J Cancer
; 126: 78-90, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31927165
20.
The Role of PI3K Inhibition in Lymphoid Malignancies.
Curr Hematol Malig Rep
; 14(5): 405-413, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31359259